We are live on ! Find out more
CLB icon

Core Laboratories

192 hedge funds and large institutions have $848M invested in Core Laboratories in 2026 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 57 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

615% more call options, than puts

Call options by funds: $443K | Put options by funds: $62K

154% more capital inflows, than outflows

Capital inflows: $104M | Capital outflows: $40.9M

39% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 18

2.04% more ownership

Funds ownership: 107.7% → 109.73% (+2%)

2% more funds holding

Funds holding: 189 → 192 (+3)

7% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 57

Holders
192
Holders Change
+3
Holders Change %
+1.59%
% of All Funds
2.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
61
Reduced
57
Closed
18
Calls
$443K
Puts
$62K
Net Calls
+$381K
Net Calls Change
-$183K

CLB Hedge Fund Activity: Q1 2026 in Review

192 of the 8,220 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q1 2026, worth a combined $848M — up 5.5% from $804M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new CLB positions and 18 closed out — a net gain of 7 holders — while 61 added to existing stakes and 57 trimmed.

The largest buyer was CWA Asset Management Group, adding an estimated $20M. The largest seller was Ariel Investments, cutting an estimated $8.78M.

  • 192 institutional investors held Core Laboratories (CLB) as of Q1 2026, up from 189 in Q4 2025.
  • Funds reported $848M of Core Laboratories stock for Q1 2026, up 5.5% quarter-over-quarter.
  • 25 funds opened new Core Laboratories positions in Q1 2026 and 18 closed out, a net change of +7 holders.
  • The largest Core Laboratories buyer in Q1 2026 was CWA Asset Management Group, an estimated $20M added.
  • The largest Core Laboratories seller in Q1 2026 was Ariel Investments, an estimated $8.78M sold.

Based on aggregated 13F filings for Q1 2026.